Natroba Suspension
Product Images NDC 84635-929

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Natroba (NDC 84635-929). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipher Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Natroba 01)

Chemical Structure (Natroba 01)
Chemical structure diagram of spinosad, the active ingredient in Natroba topical suspension 9 mg/mL by Cipher Pharmaceuticals Inc.*
FDA Label Image

Chemical Structure (Natroba 02)

Chemical Structure (Natroba 02)
Chemical structure of spinosad, the active ingredient in Natroba topical suspension 9 mg/mL by Cipher Pharmaceuticals Inc.*
FDA Label Image

Image (Natroba 03)

Image (Natroba 03)
An instructional illustration showing a hand holding a small bottle with a flip-top cap, demonstrating the motion to tilt the bottle forward and backward indicated by curved arrows, likely depicting how to properly mix or shake the suspension product prior to use.*
FDA Label Image

Image (Natroba 04)

Image (Natroba 04)
An instructional illustration showing a person lying down with eyes covered by a cloth or pad, while another hand drops liquid onto the closed eye. The image likely demonstrates the application method of an eye-related topical suspension.*
FDA Label Image

Image (Natroba 05)

Image (Natroba 05)
An instructional illustration showing a person lying down with eyes closed, a cloth or pad over the eyes, and hands gently cleaning or rubbing the scalp or hair near the forehead. A bottle is visible nearby, suggesting topical application of a liquid or suspension product.*
FDA Label Image

Image (Natroba 06)

Image (Natroba 06)
An instructional illustration showing a person applying liquid suspension to the scalp and hairline, with a clock indicating to wait 10 minutes. This image demonstrates the topical application timing guidance for Natroba (spinosad) suspension.*
FDA Label Image

Image (Natroba 07)

Image (Natroba 07)
An instructional illustration showing the application of a topical suspension to a person's scalp. One hand holds a dropper or applicator dispensing liquid, while the other hand parts the hair to expose the scalp. This image likely demonstrates the method for using Natroba (spinosad) topical suspension.*
FDA Label Image

Image (Natroba 08)

Image (Natroba 08)
An instructional illustration showing a hand holding a bottle, tilted forward and backward with arrow indicators; likely demonstrating how to shake or mix the contents of the bottle before use.*
FDA Label Image

Figure A (Natroba 09)

Figure A (Natroba 09)
Instructional illustration showing a person applying topical suspension to the inner forearm. The diagram includes an arrow indicating to move the hand back and forth along the arm, demonstrating proper application technique for Natroba suspension.*
FDA Label Image

Figure B (Natroba 10)

Figure B (Natroba 10)
An anatomical illustration showing the front and back views of a human figure. A vertical arrow runs down the back view from the shoulder to the lower back, likely indicating the application area or direction relevant to topical use.*
FDA Label Image

Figure C (Natroba 11)

Figure C (Natroba 11)
An anatomical illustration depicting front and back views of a human figure with shaded areas on shoulders, underarms, around the waist, groin, and legs. This diagram likely indicates topical treatment sites relevant to drug application instructions.*
FDA Label Image

Figure D (Natroba 12)

Figure D (Natroba 12)
An illustration showing a gray silhouette of a human figure next to a stylized stopwatch displaying a 10-minute time interval. The image suggests timing instructions related to human application.*
FDA Label Image

Figure E (Natroba 13)

Figure E (Natroba 13)
An instructional illustration showing a person wearing long clothing and a clock indicating 6 hours. This likely relates to wearing protective clothing for six hours, relevant to topical product usage guidance.*
FDA Label Image

Figure F (Natroba 14)

Figure F (Natroba 14)
An illustration showing a human figure under a showerhead with water droplets falling over the upper body, likely representing topical application or washing instructions.*
FDA Label Image

Principal Display Panel (120 mL Bottle Carton)

Principal Display Panel (120 mL Bottle Carton)
Packaging label of Natroba (spinosad) 0.9% topical suspension, 120 mL. The label shows the brand name and generic name, dosage form, strength, and volume. It includes directions to shake well before use, warnings about use in children and eye contact, and storage conditions. Distributed by Cipher Pharmaceuticals Inc. The label features a yellow and green swoosh design and barcode with the NDC 84635-929.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.